Stay updated with breaking news from Curevac the. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CureVac (NASDAQ:CVAC – Get Rating) had its price objective trimmed by JMP Securities from $34.00 to $24.00 in a research note released on Wednesday morning, The Fly reports. Other equities research analysts have also issued reports about the company. UBS Group raised CureVac from a neutral rating to a buy rating and set a $18.00 […] ....
CureVac (NASDAQ:CVAC – Get Rating) – Investment analysts at Jefferies Financial Group dropped their FY2023 earnings estimates for shares of CureVac in a report released on Tuesday, April 25th. Jefferies Financial Group analyst E. Yang now anticipates that the company will earn ($1.10) per share for the year, down from their prior forecast of ($0.99). […] ....
Investegate announcements from CureVac, CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Business Update ....
CureVac (NASDAQ:CVAC – Get Rating) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 4,110,000 shares, a growth of 13.5% from the March 15th total of 3,620,000 shares. Approximately 4.5% of the company’s shares are short sold. Based on an […] ....
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 18, 2023 / CureVac N.V. (Nasdaq:CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic ....